Navigation Links
Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
Date:5/8/2008

2008 net cash used in operating activities to be in the range of $43.0 to $48.0 million and operating expenses, including $4.0 million in restructuring and facility exit charges taken in the first quarter, to be in the range of $47.0 to $52.0 million.

Nuvelo anticipates accomplishing the following near-term milestones:

-- Initiation of a Phase 1b bolus plus infusion trial with NU172 in

healthy volunteers in the second quarter of 2008;

-- Trial completion and top-line data from the Phase 1b bolus plus

infusion trial with NU172 in the third quarter of 2008;

-- Initiation of a Phase 2 trial with NU172 in medical or surgical

procedures in the fourth quarter of 2008 or first quarter of 2009;

-- Initiation of a Phase 1 trial with NU206 in mucositis in the second

quarter of 2008;

-- Initiation of a Phase 1 single ascending dose trial with NU206 in

healthy volunteers in the third quarter of 2008;

-- Trial completion and top-line data from the Phase 1 single ascending

dose trial with NU206 in healthy volunteers in the second half of 2008;

-- Initiation of a Phase 1b multiple ascending dose trial with NU206 in

healthy volunteers in the fourth quarter of 2008 or first quarter of

2009; and

-- Advancement of a new candidate from either the Wnt Therapeutics or the

Leukemia Therapeutics Program in 2008.

Conference Call Information

Nuvelo will hold a conference call and virtual webcast today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss this announcement. To participate in the conference call, please dial 866-854-8095 for domestic callers and 706-634-8567 for international callers and reference conference passcode 43639045. A telephone replay of the conference call will be available through Thursday, May 22, 2008. To access the replay, please dial 800-642-1687 for domestic callers and 706-645-9291 for internati
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... -- Prima Biomed Ltd. (NASDAQ: PBMD ) a globally ... leader in the development of immunotherapeutic products for the ... data from the Phase II CAN-003 ovarian cancer clinical ... meaningful improvement in Overall Survival ("OS") over standard of ... the group of second remission patients (n=20), the median ...
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8Specialty Pharmacy Times Joins BPA Worldwide 2Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2
... ... ... today announced it has made two cotton acquisitions in India to enhance its product lineup ... the cotton seed business of Nandi Seeds, based in Mehboob Nagar, Andhra Pradesh, India, and ...
... Del. and MONHEIM, Germany, June 25 DuPont (NYSE: ... into a series of long-term business agreements related to ... help increase agricultural productivity around the world. , ... for both parties through herbicide and seed sales as ...
... Qforma, an advanced analytics and predictive modeling ... and field operations positions: Mark J. Grove is appointed Senior ... Qforma from Director, Field Operations to Vice President, Sales and ... Directors, Field Operations. , , These appointments follow a ...
Cached Biology Technology:DuPont Adds Cotton to India Seed Product Lineup 2DuPont Adds Cotton to India Seed Product Lineup 3DuPont Adds Cotton to India Seed Product Lineup 4DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 2DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 3DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 4Qforma Appoints Four Executives in Sales and Field Operations 2Qforma Appoints Four Executives in Sales and Field Operations 3
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, ... control and security systems is pleased to announce that ... as a consultant and member of its scientific advisory ... widely known as a thought leader in technology-enhanced learning ... Technology Group, and has published studies and books focused ...
(Date:4/17/2015)... Increasing adoption in ... to drive biometric systems market in ... According to a recently released TechSci Research ... biometric systems market in Saudi Arabia ... CAGR of over 22% through 2020. The market ...
(Date:4/13/2015)... 13, 2015  higi, a leading cloud-based consumer engagement ... fully engage with their communities around health and wellness, ... and secure API.  ... accessible, affordable, and convenient vehicle to receive validated health ... The API will allow higi,s trusted partners, ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... to synchronize the pitch of their calls with an extremely high ... call to call, according to a new study of the blue ... the Journal of the Acoustical Society of America . The ... could allow individual whales to locate potential mates by swimming toward ...
... bowel syndrome has been traced to a small piece of ... to hostile conditions that can produce diarrhea, bloating and chronic ... sends signals that stop the activity of the gene that ... shortage of glutamine in the gut with the seepage of ...
... that could lead to new drugs that reduce the ... in the August 2010 issue of Journal of ... with the function of the cell membrane protein called ... relevant model of severe infection. "Clinical trials ...
Cached Biology News:Blue whales align the pitch of their songs with extreme accuracy, study finds 2Scientists target possible cause of 1 form of bowel disease 2Scientists target possible cause of 1 form of bowel disease 3
... the proven features of the pET, BacVector ... all of the benefits and versatility of ... The pTriEx vectors have been extensively tested ... all three expression systems. In each case, ...
Rabbit polyclonal to Shigella Immunogen: Mixture of S. boydii, S. flexneri & S. dysenteriae....
... ALDEFLUOR Stem Cell Identification ... comprises a substrate for ... (ALDH) that is highly ... stem cells, making ALDH ...
Yellow oily liquid. Contains 85% Drakeol 5NF, 15% Arlacel A (mannide monooleate emulsifier). Heat sterilized. Contains zero colony forming units/ml. ...
Biology Products: